A NOVEL PPAR-GAMMA AGONIST, AS002, INDUCES PPAR-GAMMA-ACTIVITY IN ULCERATIVE COLITIS MUCOSA, AND PREVENTS AND REVERSES INFLAMMATION IN DSS COLITIS.
Stéphanie Da Silva 1
Åsa V. Keita 1
Sofie Mohlin 2
Sven Pahlman 3
Ingrid Pahlman
Johan D. Söderholm
1 Department of Clinical and Experimental Medicine,Faculty of Health Sciences Linköping University,Linköping,Sweden
2 Translational Cancer Research,Cancer Center at Medicon Village,Lund,Sweden
3 Translational Cancer Research,Ca
Conference
UEG Week 2015
Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]